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Background and aims: In a large stroke-free population, we sought to identify cardiovascular risk factors
and carotid plaque components associated with carotid plaque burden, lumen volume and stenosis.
Methods: The carotid arteries of 1562 stroke-free participants from The Rotterdam Study were imaged on
a 1.5-Tesla MRI scanner. Inner and outer wall of the carotid arteries were automatically segmented and
lumen volume (mm3), wall volume (outer walleinner wall) and plaque burden (wall volume/outer wall
volume) (%) were quantiﬁed. Plaque components were visually determined and luminal stenosis was
assessed. We analyzed associations of cardiovascular risk factors and carotid plaque components with
plaque burden and lumen volumes using regression analysis.
Results: We investigated 2821 carotid plaques and found that women had larger plaque burden
(50.7 ± 7.8% vs. 49.2 ± 7.7%, p < 0.0001) and smaller lumen volumes (933 ± 286 mm3 vs. 1078 ± 334 mm3,
p < 0.0001) than men. In women, age, HDL-cholesterol and systolic blood pressure, and in men, total
cholesterol, non-HDL cholesterol and statin use were independently associated with higher plaque
burden and lumen volume. Furthermore, smoking and diabetes were associated with lumen volume in
men (respectively p ¼ 0.04 and p ¼ 0.002). Intraplaque hemorrhage (IPH) and lipid were related to a
larger plaque burden (OR 1.30 [1.05e1.60] and OR 1.28[1.06e1.55]). Finally, within the highest quartile of
plaque burden, IPH was strongly associated with luminal stenosis independent of age, sex, plaque burden
and composition (Beta ¼ 15.2; [11.8e18.6]).
Conclusions: Several cardiovascular risk factors and plaque components, in particular IPH, are associated
with higher plaque burden. Carotid IPH is strongly associated with an increased luminal stenosis.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Subclinical carotid atherosclerosis is highly prevalent among the
elderly and is a common cause of cerebrovascular disease. Direct
non-invasive measurements of the burden and composition ofgh-density lipoprotein; IPH,
aging.
, Erasmus MC, P.O. Box 2040,
tzel).
r Ireland Ltd. This is an open accesasymptomatic atherosclerotic plaque have, therefore, been pro-
posed as a way to improve cardiovascular disease prevention and
management. Plaque burdenmay provide more information on the
extent of atherosclerosis beyond luminal stenosis [1,2]. Further-
more, it has been postulated that plaque burden is associated with
an increased risk of stroke and coronary heart disease [3e7].
Different imaging techniques have been used to quantify and
monitor carotid plaque burden and luminal stenosis. Studies that
used ultrasound to assess carotid plaque burden are limited,
because of the low contrast-to-noise ratio of US for the detection of
plaque components [8]. Whereas computed tomography has beens article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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detection of soft non-calciﬁed plaques remains limited. Magnetic
resonance imaging (MRI) depicts the plaque composition as well as
the inner and outer wall of the entire carotid artery and is non-
invasive in nature. Hence, MRI may be a promising modality to
investigate atherosclerotic plaque burden in the general popula-
tion. Though some previous studies investigated plaque volume on
MRI using manual segmentation, these studies were mostly con-
ducted in selected or small samples [9e11]. Semi-automated seg-
mentation of atherosclerotic plaque may provide a fast, accurate
and reproducible tool for large-scale application [12,13].
Information on determinants of plaque burden and lumen vol-
ume in the general population remains scarce. In addition, it is still
unclear how (vulnerable) plaque components relate to overall
plaque burden and lumen reduction. Therefore, we quantiﬁed ca-
rotid atherosclerotic plaque burden and lumen volume in a large
population of stroke-free subjects and determined sex-speciﬁc
associations with cardiovascular risk factors and carotid plaque
composition. In addition, we evaluated the role of carotid plaque
components in the development of luminal stenosis.
2. Materials and methods
2.1. Study population
The study is part of the Rotterdam Study, a large population-
based cohort study, which was designed to investigate de-
terminants of various diseases among the elderly. The Rotterdam
Study has been approved by the medical ethics committee ac-
cording to the Population Study Act Rotterdam Study, executed by
the Ministry of Health, Welfare and Sports of the Netherlands. A
written informed consent was obtained from all participants. All
inhabitants of Ommoord, a suburb of Rotterdam, aged 45 years and
over were invited. The rationale and design of the Rotterdam Study
have been described elsewhere [14]. As part of the baseline ex-
aminations, all participants underwent ultrasonography to mea-
sure carotid wall thickness and underwent carotid MRI if wall
thickness was 2.5 mm in at least one carotid artery (n ¼ 1982
subjects, 74% of those initially invited) [15]. Participants who had a
past medical history positive for stroke (deﬁned as a history of
ischemic or unspeciﬁed stroke but not hemorrhagic stroke) or TIA
were excluded (n ¼ 95). In addition, MRI scans were excluded if
visual quality was insufﬁcient for assessment of plaque composi-
tion (n ¼ 113) or if scanning was interrupted due to claustrophobia
(n ¼ 106). We further excluded carotid arteries without athero-
sclerotic plaque or if wall thickness was <2 mm on MRI (n ¼ 284).
This resulted in a total of 3052 carotid arteries in 1668 scanned
participants available for analysis.
2.2. Carotid MRI scanning and visual analysis of plaque
characteristics
Imaging was performed with a 1.5 Tesla scanner (GE Healthcare,
Milwaukee, WI, USA) with a bilateral phased-array surface coil
(Machnet, Eelde, the Netherlands). A standard scanning protocol
was used with a total scanning time of approximately 30 min. The
carotid MRI protocol, reading and reproducibility are described
elsewhere, and include four sequences in the axial plane: a proton
density weighted (PDw)-fast spin echo (FSE)-black blood (BB)
sequence; a PDw-FSE-BB with an increased in-plane resolution; a
PDw-echo planar imaging (EPI) sequence, and a T2w-EPI sequence
and two 3D sequences: a 3D-T1w-gradient echo (GRE) sequence
and a 3D phased-contrast MR angiography [16]. We evaluated both
carotid arteries and assessed plaque characteristics in all plaques
with a maximum thickness of 2.0 mm on MRI. On the PDw-FSE-BB images, maximum carotid wall thickness was measured and
degree of luminal stenosis was calculated using the North American
Symptomatic Carotid Endarterectomy Trial NASCET criteria [17].
Plaques were visually reviewed for the presence of three different
plaque components; presence of intraplaque hemorrhage (IPH),
lipid core and calciﬁcation as described previously and multiple
components were permitted within one plaque [15].
2.3. Automated segmentation of lumen volume and plaque burden
The MRI-based automated method for carotid lumen and wall
volume quantiﬁcation, as described by Van ‘t Klooster et al. [13] and
Hameeteman et al. [12] was used. The method showed comparable
results to the manual annotations in terms of wall volume and
normalized wall index measurements and can therefore be used to
replace the manual annotations. Using the PDw-FSE-BB sequence
and 3D phased-contrast MR image, the method automatically
quantiﬁes the lumen volume and plaque burden of the carotid ar-
tery in a region around the bifurcation. Brieﬂy, the method com-
bines lumen and outer wall segmentation based on deformable
model ﬁtting with a learning-based segmentation correction step.
In order to ensure a similar coverage among carotid arteries, we
included segments of approximately 25mm length in central vessel
axis centered at the bifurcation point; i.e. 12.5 mm segment length
on both sides from the bifurcation point to the common and in-
ternal carotid artery. The bifurcation point was manually annotated
and deﬁned as the ﬁrst transversal plane on which two separate
lumens (one of the internal carotid artery and one of the external
carotid artery) are visible. Volumes of the lumen (mm3) and outer
vessel wall of the carotid arteries were obtained using a custom-
designed automatic image analysis tool [12], thus eliminating the
need for manual contouring. User input was limited to four seed
points in the common, internal and external carotid artery and
bifurcation. Wall volume was calculated as the difference between
the outer vessel wall volume and lumen volume. Plaque burden
was operationalized by measuring wall volume/outer vessel wall
volume and multiplied by 100%.
In total, 2923 extracted volumes of the lumen and outer vessel
wall were available. Missing extracted volumes (n ¼ 129, (7.6%))
were due to incomplete MRI data (n ¼ 50), failure of image regis-
tration between PDw-FSE-BB and phase-contrast MRA sequences
(n ¼ 20) or failure of automated segmentation (n ¼ 59). Based on
visual inspection, 3 outliers were removed because of suboptimal
segmentation, and volumes that are further than three standard
deviations from the mean were also considered as outliers and
removed (n ¼ 99). In total, n ¼ 2821 carotid arteries (in n ¼ 1562
individuals) were used for the statistical analyses.
2.4. Covariates
Smoking status was classiﬁed as ever or never. Serum high-
density lipoprotein (HDL)-cholesterol (mmol/L) and total choles-
terol (mmol/L) were measured using standard laboratory tech-
niques. Non-HDL cholesterol (mmol/L) was calculated as the
difference between total and HDL-cholesterol. Body mass index
(BMI) [weight/height2], expressed in kg/m2, was determined for all
subjects. Blood pressure (mmHg) was measured with a random-
zero sphygmomanometer after 5 min of rest with the subject in a
sitting position and the mean of the two blood pressure values was
used. Diabetes mellitus was deﬁned as a fasting blood glucose
>7.0 mmol/L, non-fasting glucose >11.0 mmol/L, or use of antidia-
betic medication. Hypertension was deﬁned as a blood pressure
>140/90 mmHg or the use of antihypertensive medication. Medi-
cation dispensing data were obtained from the fully computerized
pharmacies in the Ommoord suburb. Information on all ﬁlled
Table 1
Baseline characteristics of 1562 study participants.
Variable Overall Men (839) Women (723) p-value
Age (years) 72.7 ± 9.2 72.1 ± 8.9 73.4 ± 9.4 0.005
Smoking (ever) (%) 73.6 85.0 60.4 <0.001
HDL-cholesterol (mmol/L) 1.4 (0.4) 1.3 (0.3) 1.6 (0.4) <0.001
Total cholesterol (mmol/L) 5.7 (1.0) 5.4 (1.0) 5.9 (1.0) <0.001
Non-HDL cholesterol (mmol/L) 4.3 (1.0) 4.2 (1.0) 4.4 (1.0) <0.001
BMI (kg/m2) 27.3 (3.6) 27.4 (3.1) 27.1 (4.0) 0.1
Systolic blood pressure (mmHg) 145 (21) 145 (20) 145 (22) 0.8
Diastolic blood pressure (mmHg) 80 (11) 82 (11) 79 (11) <0.001
Diabetes (%) 13.9 16.4 10.9 0.002
Hypertension (%) 74.5 75.1 73.9 0.7
Antihypertensive drugs (%) 39.7 40.3 39.0 0.6
Statins (%) 27.7 32.1 22.7 <0.001
Values are percentages or means (SD).
p-value is for age-adjusted differences between men and women.
(Non)-HDL, high-density lipoprotein; BMI, body mass index.
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date of carotid MRI scans was available.
2.5. Data analysis
Lumen volume and plaque burden were normalized for carotid
artery length and adjusted for age. Sex-speciﬁc relationships of
cardiovascular risk factors with plaque burden and lumen volume
were assessed bymeans of generalized estimation equationwith an
unstructured working correlation matrix including two levels per
participant, namely the left and right carotid artery. Continuous
variables were expressed per standard deviation (SD) and plaque
burden and lumen volumes were transformed to a standardized Z-
score in order to allow comparison across these measures. Ad-
justments were made for age and carotid segment length (model
1), and additionally for smoking, HDL-cholesterol, total cholesterol,
BMI, systolic blood pressure, diastolic blood pressure, diabetes
mellitus, hypertension, antihypertensive drug use and statin use
(model 2). Non-HDL was additionally adjusted for the same cova-
riates as in model 2, but without HDL-cholesterol and total
cholesterol (model 3).
In secondary analysis, we categorized lumen volume and plaque
burden using sex-speciﬁc quartiles and compared the lowest
quartile in lumen volume and the highest quartile of plaque burden
to the other three quartiles, respectively. In addition, we studied the
odds ratio (OR) for prevalence of different plaque components (i.e.,
hemorrhage, calciﬁcation and lipid) in relation to lowest quartile of
lumen volume and the highest quartile of plaque burden and we
tested for effect modiﬁcation by sex. Finally, within each quartile of
plaque burden, we investigated the association of all plaque com-
ponents with luminal stenosis. Longitudinal coverage of carotid
arteries was not equal for all MRI scans. In order to evaluate the
effect of variation in carotid segment length, we additionally per-
formed a sensitivity analysis for which we excluded carotid arteries
with a segment length <25mm. All analyses were carried out using
SPSS Statistical Package version 20.0 (Chicago, IL, USA).
3. Results
Table 1 describes the baseline characteristics of the study pop-
ulation. In a total of 1562 individuals, mean agewas 72.7 ± 9.2 years
and 723 (46%) were women. Women were slightly older, smoked
less, had higher HDL-cholesterol, total cholesterol and non-HDL
cholesterol values, lower diastolic blood pressure, less often dia-
betic and used less statins (age-adjusted p-values <0.002). In
comparison to men, women had smaller lumen volumes
(933 ± 286 mm3 vs.1078 ± 334mm3 in men, p < 0.0001) and largerplaque burden (50.7 ± 7.8% vs. 49.2 ± 7.7% in men, p < 0.0001).
In Table 2A and B, we reported the sex-speciﬁc associations
between cardiovascular risk factors, lumen volume and plaque
burden after adjustment for age and segment length (model 1) as
well as all other cardiovascular risk factors (model 2 or 3). In
women, younger age, lower HDL-cholesterol and higher systolic
blood pressure were independently associated with larger plaque
burden and smaller lumen volume, whilst in men, higher total
cholesterol and non-HDL cholesterol levels and statin use were
related to higher plaque burden and lower lumen volume. Also,
ever smoking and diabetes were associated with lumen volume in
men.
Lipid, IPH and calciﬁcations were present in 28,6%, 21,5% and
70,8% of the 2821 carotid atherosclerotic plaques. Table 3 shows the
association of the various plaque components with low lumen
volume (lowest quartile vs. others) and high plaque burden
(highest quartile vs. others). With respect to lumen volume or
plaque burden, there was no interaction between sex and plaque
component (data not shown), therefore we did not stratify for sex.
In sex and age-adjusted analysis, IPH and lipid were signiﬁcantly
associatedwith low lumen volume (OR 1.42 [1.15e1.75] and OR 1.34
[1.12e1.62], respectively) and with high plaque burden (OR 1.30
[1.05e1.60] and OR 1.28 [1.06e1.55], respectively).
Finally, we investigated the relation between plaque compo-
nents and luminal stenosis across the four quartiles of plaque
burden (Fig. 1, Table 4). Fig. 1 shows a graphical distribution of the
mean luminal stenosis in carotid arteries conditioned on plaque
composition per quartile of plaque burden. Table 4 shows that IPH
yielded the strongest association with luminal stenosis, indepen-
dent of age, sex, plaque burden and the other plaque components in
all quartiles of plaque burden.
The sensitivity analysis for which we excluded carotid arteries
with a segment length <25 mm (n ¼ 503 (16.7%)) on MRI, resulting
in a total of n¼ 2500 carotid arteries (n¼ 1553 individuals) did not
materially lead to different results (Supplemental Tables 1 and 2).
4. Discussion
In this population-based study in stroke-free subjects, we found
that several cardiovascular risk factors are associated with carotid
plaque burden and lumen volume as measured on MRI. Younger
age, lower HDL-cholesterol levels and higher systolic blood pres-
sures were associatedwith larger plaque burden and smaller lumen
volume in women, whilst in men, signiﬁcant associations were
observed with total cholesterol and non-HDL cholesterol levels and
statin use. Furthermore, we found IPH and lipid to be associated
with low lumen volume and high plaque burden. Across all
Table 2
Cardiovascular determinants for lumen volume and plaque burden. (A) In women, (B) in men.
Variable Z-score Z-score
Lumen volume Plaque burden
Beta 95% CI p-value Beta 95% CI p-value
(A)
Model 1
Age 0.103 [0.051; 0.156] <0.001 0.085 [0.142; 0.027] 0.004
Smoking (ever) 0.062 [0.005; 0.130] 0.07 0.049 [0.126; 0.028] 0.2
HDL-cholesterol 0.070 [0.018; 0.122] 0.008 0.075 [0.131; 0.019] 0.008
Total cholesterol 0.028 [0.082; 0.026] 0.3 0.003 [0.060; 0.065] 0.9
Non-HDL cholesterol 0.051 [0.101; 0.002] 0.04 0.030 [0.029; 0.089] 0.3
BMI 0.009 [0.055; 0.038] 0.7 0.031 [0.020; 0.082] 0.2
Systolic blood pressure 0.026 [0.084; 0.033] 0.4 0.044 [0.016; 0.105] 0.1
Diastolic blood pressure 0.020 [0.039; 0.078] 0.5 0.012 [0.079; 0.055] 0.7
Diabetes 0.043 [0.226; 0.140] 0.6 0.086 [0.094; 0.265] 0.3
Hypertension 0.040 [0.098; 0.179] 0.6 0.020 [0.160; 0.119] 0.8
Antihypertensives 0.009 [0.111; 0.130] 0.9 0.010 [0.118; 0.138] 0.9
Statins 0.087 [0.212; 0.038] 0.2 0.045 [0.100; 0.190] 0.5
Model 2
Age 0.134 [0.066; 0.203] <0.001 0.118 [0.187; 0.048] 0.001
Smoking (ever) 0.067 [0.003; 0.137] 0.06 0.053 [0.131; 0.025] 0.2
HDL-cholesterol 0.081 [0.024; 0.137] 0.005 0.075 [0.134; 0.015] 0.01
Total-cholesterol 0.038 [0.093; 0.017] 0.2 0.014 [0.050; 0.78] 0.7
Non-HDL cholesterol3 0.037 [0.090; 0.016] 0.2 0.013 [0.049; 0.076] 0.7
BMI 0.0004 [0.052; 0.052] 1.0 0.019 [0.034; 0.073] 0.5
Systolic blood pressure 0.094 [0.175; 0.014] 0.02 0.112 [0.029; 0.196] 0.009
Diastolic blood pressure 0.065 [0.011; 0.141] 0.09 0.068 [0.156; 0.020] 0.1
Diabetes 0.008 [0.180; 0.195] 0.9 0.024 [0.163; 0.210] 0.8
Hypertension 0.107 [0.059; 0.272] 0.2 0.125 [0.308; 0.058] 0.2
Antihypertensives 0.020 [0.118; 0.157] 0.8 0.013 [0.158; 0.131] 0.9
Statins 0.087 [0.225; 0.050] 0.2 0.023 [0.135; 0.180] 0.8
(B)
Model 1
Age 0.013 [0.077; 0.052] 0.7 0.011 [0.070; 0.048] 0.7
Smoking (ever) 0.087 [0.00; 0.174] 0.050 0.022 [0.104; 0.061] 0.6
HDL-cholesterol 0.055 [0.024; 0.134] 0.2 0.030 [0.106; 0.047] 0.4
Total cholesterol 0.022 [0.083; 0.039] 0.5 0.048 [0.007; 0.103] 0.09
Non-HDL cholesterol 0.039 [0.100; 0.022] 0.2 0.058 [0.003; 0.113] 0.04
BMI 0.034 [0.106; 0.037] 0.3 0.059 [0.011; 0.128] 0.1
Systolic blood pressure 0.001 [0.069; 0.070] 1,0 0.023 [0.086; 0.040] 0.5
Diastolic blood pressure 0.018 [0.045; 0.081] 0.6 0.037 [0.095; 0.020] 0.2
Diabetes 0.270 [0.422; 0.119] <0.001 0.131 [0.007; 0.268] 0.06
Hypertension 0.045 [0.199; 0.109] 0.6 0.036 [0.174; 0.102] 0.6
Antihypertensives 0.022 [0.150; 0.107] 0.7 0.062 [0.179; 0.055] 0.3
Statins 0.158 [0.293; 0.024] 0.02 0.112 [0.011; 0.235] 0.07
Model 2
Age 0.004 [0.080; 0.073] 0.9 0.015 [0.083; 0.053] 0.6
Smoking (ever) 0.092 [0.003; 0.181] 0.04 0.034 [0.118; 0.050] 0.4
HDL-cholesterol 0.040 [0.045; 0.125] 0.4 0.026 [0.108; 0.057] 0.5
Total cholesterol 0.073 [0.140; 0.006] 0.03 0.071 [0.012; 0.130] 0.02
Non-HDL cholesterol3 0.072 [0.136;0.008] 0.03 0.069 [0.012; 0.126] 0.02
BMI 0.018 [0.094; 0.059] 0.6 0.058 [0.017; 0.133] 0.1
Systolic blood pressure 0.013 [0.108; 0.081] 0.8 0.008 [0.076; 0.091] 0.9
Diastolic blood pressure 0.037 [0.044; 0.118] 0.4 0.049 [0.125; 0.027] 0.2
Diabetes 0.262 [0.426; 0.098] 0.002 0.134 [0.011; 0.278] 0.07
Hypertension 0.053 [0.249; 0.143] 0.6 0.006 [0.174; 0.186] 0.9
Antihypertensives 0.057 [0.087; 0.200] 0.4 0.116 [0.247; 0.014] 0.08
Statins 0.155 [0.302; 0.009] 0.04 0.163 [0.031; 0.296] 0.02
Values are adjustedmean differences (95% conﬁdence interval) in lumen volume and plaque burden, expressed in Z-scores, per increase in SD or presence of each determinant.
Model 1 adjusted for age and segment length.
Model 2 adjusted for cardiovascular risk factors (smoking, HDL-level, total cholesterol, BMI, systolic blood pressure, diastolic blood pressure, diabetes mellitus, hypertension,
antihypertensive drug use and statin use).
Model 3 same as model 2 but without HDL-cholesterol and total cholesterol.
(Non)-HDL, high-density lipoprotein; BMI, body mass index. CI, conﬁdence interval.
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was related to more severe luminal stenosis, however, this was
most pronounced for IPH.
To our knowledge, this is the largest study to date to take
advantage of MRI-based automated segmentation to quantify pla-
que burden and lumen volumes in a stroke-free population. All
participants were preselected on presence of advancedatherosclerotic plaque on ultrasound. Bilateral plaque burden
characterization was achieved with minimal user interaction. The
longitudinal coverage of 25 mm in central vessel axis permitted by
the automated segmentation allows detection of atherosclerotic
plaques in the common and internal carotid artery, which can be
potentially missed with ultrasound or computed tomography im-
aging. Restricting our study to a stroke-free population allowed us
Table 3
Association of different plaque components with low lumen volume (lowest quartile
vs. other three quartiles), high plaque burden (highest quartile vs. other three
quartiles).
Low lumen volume High plaque burden
OR 95% CI p-value OR 95% CI p-value
IPH 1.42 [1.15; 1.75] 0.001 1.30 [1.05; 1.60] 0.02
Lipid 1.34 [1.12; 1.62] 0.002 1.28 [1.06; 1.55] 0.009
Calciﬁcation 0.92 [0.76; 1.11] 0.4 1.02 [0.84; 1.25] 0.8
Age and sex-adjusted.
OR, odds ratio; CI, conﬁdence interval; IPH, intraplaque hemorrhage.
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that had enough power to do so were performed stratiﬁed on sex,
because atherosclerosis distributions are known to be different
amongst men and women.
Although the automatic quantiﬁcation of atherosclerosis was
highly reproducible, this step remains difﬁcult, because of the
limited tissue contrast between the outer vessel wall and the sur-
rounding soft tissues, limiting the accuracy of outer vessel wall
contouring. Furthermore, the automatic tool is not able to differ-
entiate between the intimal thickening and the media and adven-
titia. Both limitations may have resulted in a systematic
overestimation of plaque volume measurements, which we expect
to be non-differential. We found no clear deﬁnitions of plaque
burden measurement in the literature as different imaging tech-
niques have previously been used to quantify plaque burden [18]. In
our study, we decided to operationalize plaque burden using wall
volume (outer vessel wall volume e lumen volume), relative to the
outer vessel volume, normalized to carotid artery length, as this is a
practical approach to evaluate, this value across a large number of
study subjects. Nevertheless, it must be noted that our ﬁndings
cannot be directly compared to the various studies on this issue.
Our cross-sectional study design restricted our interpretation of the
data with respect to cause and consequence. For this reason, pro-
spective longitudinal studies should investigate the association of
cardiovascular risk factors with plaque progression.
Previous studies using different imaging modalities like ultra-
sound or computed tomography have demonstrated the potential
to use plaque burden measurements as a direct measure of the
extent and severity of atherosclerotic disease [19]. Plaque mea-
surements in these studies have varied between estimation of theFig. 1. Mean luminal stenosis in carotid arteries conditioned on plaque composition per
signiﬁcantly larger luminal stenosis than carotid arteries without the condition (adjusted fintima medial thickness and luminal stenosis on ultrasound to
measurement of calciﬁed plaque burden on CT [1,20,21]. Never-
theless, studies that investigated the association of cardiovascular
risk factors in relation to plaque burden measurements using MRI
remain scarce. In the previous studies, independent associations
were detected between plaque burden and smoking, HDL-
cholesterol, total cholesterol, non-HDL cholesterol and systolic
blood pressure [1,20,21]. In 1670 subjects from the general popu-
lation, the Atherosclerosis Risk in Communities (ARIC) study
demonstrated that carotid plaque burden, automatically measured
on MRI, was associated with atherogenic cholesterol, such as total
cholesterol, non-HDL cholesterol and low HDL-cholesterol levels
[21]. In concordance to these ﬁndings, our study showed signiﬁcant
associations in both sexes between atherogenic cholesterol and
higher plaque burden and smaller lumen volume.
In addition, whereas sex differences regarding the severity of
atherosclerosis are widely known, several studies conﬁrm that
plaque composition as well as outcomes in vascular disease differ
between sexes [22e25]. In our study, it is possible that a higher
relative plaque burden in women may be partly explained by the
smaller artery size in women than in men, whereas absolute
amount of plaque may be equal or less than in men. Nevertheless,
our study underlines the importance of sex-differentiated man-
agement in patients with asymptomatic carotid atherosclerosis
across all stages of carotid stenosis.
When examining plaque composition, we found lipid and IPH to
be independently associated with low lumen volume and high
plaque burden. These ﬁndings are consistent with results from
prior studies that investigated the relation of plaque composition to
plaque volumes and in which high plaque volume was often
associated with a large lipid core [26e28]. Although these studies
provide insight on the association between plaque components and
plaque burden in more advanced atherosclerosis, none considered
the role of IPH. When we took into account differences in total
plaque burden, we found that persons with IPH had the largest
degree of stenosis compared to persons with lipid or calciﬁcation.
These ﬁndings suggest that the presence of IPH is associated with
more severe luminal narrowing independent of the size of the
plaque. One hypothesis could be that IPH develops so fast that it
overrules preservation of luminal patency by outward remodeling.
In our data, this hypothesis is supported by the fact that the outer
vessel wall volume of carotid arteries with IPH is signiﬁcantlyquartile of plaque burden. All carotid arteries with the condition are associated with a
or age, sex, plaque burden, segment length) p  0.005. IPH, intraplaque hemorrhage.
Table 4
Risk of luminal stenosis with presence of different plaque components stratiﬁed on quartile of plaque burden.
Plaque burden Intraplaque hemorrhage Lipid Calciﬁcation
Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value
1st quartile 6.0 [3.6; 8.4] <0.001 3.0 [0.9; 5.1] 0.005 2.4 [0.2; 4.6] 0.03
2nd quartile 6.8 [4.3; 9.3] <0.001 5.1 [2.8; 7.3] <0.001 4.4 [2.1; 6.6] <0.001
3rd quartile 10.6 [7.7; 13.4] <0.001 5.6 [3.2; 8.1] <0.001 3.3 [0.9; 5.8] 0.008
4th quartile 15.2 [11.8; 18.6] <0.001 6.8 [3.7; 9.9] <0.001 5.3 [1.9; 8.6] 0.002
Linear regression analysis: all models include sex, age, segment length, plaque burden, lipid, IPH, calciﬁcation. Beta indicates risk of luminal stenosis (dependent variable) with
presence of different plaque components stratiﬁed on quartile of plaque burden.
CI, conﬁdence interval.
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segment length and plaque burden (1943 mm3 vs 1996 mm3;
p < 0.001). Our ﬁndings are also consistent with the ﬁndings of
Takaya et al. who showed that lesions with IPH at baseline had a
greater increase in wall volume and reduction in lumen volume
compared with arteries without IPH after eighteen months of
follow up [29]. It is well established in the literature that the IPH
component is one of the critical factors of the vulnerable carotid
artery plaque [30,31]. Although it was suggested that the increased
cardiovascular risk of IPH is due to plaque destabilization with
thromboembolic complications [32,33], we now show that IPH also
strongly contributes to lumen narrowing, in the context of equal
plaque burden.
Current screening and diagnostic methods are insufﬁcient to
identify the plaques that have a high rupture risk and thus to
adequately select individuals who are most likely to suffer
from an ischemic stroke. Although still challenging, future
research should test the hypothesis whether assessment of pla-
que burden and (vulnerable) plaque components, as opposed to
simple stenosis measurements with carotid ultrasound, may
contribute to optimized risk classiﬁcation and treatment
strategies.
Sex-speciﬁc cardiovascular risk factors, such as age, HDL-
cholesterol, total cholesterol, non-HDL cholesterol, systolic blood
pressure, smoking, diabetes and statin use, and plaque composition
are associated with plaque burden and lumen volume. Amongst
different plaque components, IPH yields the strongest association
with luminal stenosis. Hence, the control of modiﬁable risk factors
can prove beneﬁcial in lowering plaque burden. However, pro-
spective longitudinal studies should investigate whether these
cardiovascular risk factors and plaque components are also asso-
ciated with plaque progression.
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